🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Status
Completed
Location
The Mayo Clinic - Phoenix
Start Date
2017-03-06
Trial ID
NCT03009981
Treatments Being Tested
Asymptomatic patients with metastatic castrate resistant prostate cancer (m...
Status
Recruiting
Location
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Start Date
2023-10-04
Trial ID
NCT06059118
Treatments Being Tested
This is an observational study in which patient data from the past on men w...
Status
Completed
Location
Databases
Start Date
2022-01-17
Trial ID
NCT05149131
Treatments Being Tested
This phase II trial studies how well apalutamide, abiraterone acetate, pred...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2017-03-09
Trial ID
NCT02849990
Treatments Being Tested
This phase II trial studies the effect of talazoparib with androgen depriva...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2021-05-04
Trial ID
NCT04734730
This phase II trial studies how well finite androgen ablation with or witho...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2013-02-05
Trial ID
NCT01786265
In April 2011, the United States Food and Drug Administration (FDA) approve...
Status
Completed
Location
Northwestern University, Feinberg School of Medicine
Start Date
2012-12-18
Trial ID
NCT01751451
Treatments Being Tested
Oligo-metastatic prostate cancer (OMPCa) is considered as an intermediated ...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2022-04
Trial ID
NCT05212857
This study is being conducted to assess the safety and tolerability of relu...
Status
Completed
Location
Urological Associates of Southern Arizona, P.C.
Start Date
2021-02-18
Trial ID
NCT04666129
Treatments Being Tested
This study is a single-centre, randomised, paired 24-week intervention dosi...
Status
Not Yet Recruiting
Location
Changzheng hospital
Start Date
2026-02
Trial ID
NCT07389174
Treatments Being Tested